MCAP MediaWire
17 Feb 2026, 19:20 UTC · 31w ago
Verdict
Headline takes no side. We score CRTD +0.60 across three claims — strongly bullish.
+0.60strongly bullish
More positive than 74% of ticker scores this week
What the story claims
3 claims · scored −1 bearish … +1 bullish
Catheter Precision, Inc. (VTAK) has acquired a 20% equity interest in Fly Flyte, Inc., a subsidiary of Creatd, Inc. (CRTD).
So whatStrategic investment and partnership between a NYSE American listed company and a subsidiary of an OTC company generally provides a positive signal for the valuation of the smaller entity.
More positive than 64% of claims this week
Fly Flyte, Inc. is currently operational, providing AI-enabled regional aviation services.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
More positive than 51% of claims this week
Creatd, Inc. is pursuing a strategy to build a portfolio of operating companies in the small-cap space using a shared services model.
More positive than 42% of claims this week
Which stocks this story touches
More positive than 74% of ticker scores this week
The company is executing its strategy of building a portfolio of scalable subsidiaries and bringing in a new strategic partner.
More positive than 64% of ticker scores this week
The company is expanding its portfolio through the acquisition of a 20% interest in an AI-enabled aviation services subsidiary.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
[a_to_b] VTAK acquired a 20% equity interest in Fly Flyte, a subsidiary of CRTD.
−62.2%
Price is moving against the score
$3.40 vs $9.00 close before publication (Feb 13) · not market-adjusted
CRTD chart →
